Krsnaa DiagnosticsNSE:KRSNAA +2.22%72 Days Payable is 98.29 as of Mar. 2026, which is 31% below its 10-year median of 141.76. GuruFocus rates NSE:KRSNAA with a GF Score™ of 72/100 and a GF Value™ of ₹904.34 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 191 Medical Diagnostics & Research companies, Krsnaa Diagnostics ranks better than 75.39% on this metric.
The historical rank and industry rank for Krsnaa Diagnostics's Days Payable or its related term are showing as below:
NSE:KRSNAA'
s Days Payable Range Over the Past 10 Years
Min: 110.91 Med: 141.76 Max: 191.21
Current: 151.6
During the past 8 years, Krsnaa Diagnostics's highest Days Payable was 191.21. The lowest was 110.91. And the median was 141.76.
NSE:KRSNAA's Days Payable is ranked better than 75.39% of 191
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.09
vs NSE:KRSNAA: 151.60
Krsnaa Diagnostics's Days Payable
declined
from Mar. 2025 (150.34) to Mar. 2026 (98.29).
It may suggest that Krsnaa Diagnosticsaccelerated paying its suppliers.
Krsnaa Diagnostics Days Payable Related Terms
Krsnaa Diagnostics Days Payable Historical Data
* Premium members only.
The historical data trend for Krsnaa Diagnostics's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:KRSNAA vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Krsnaa Diagnostics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krsnaa Diagnostics Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's Days Payable distribution charts can be found below:
* The bar in red indicates where Krsnaa Diagnostics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Krsnaa Diagnostics's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krsnaa Diagnostics (NSE:KRSNAA) has a Days Payable of 98.29 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Krsnaa Diagnostics and its competitors. This is 31% below median its historical median of 141.76. Over the past decade, Krsnaa Diagnostics' Days Payable has ranged from 110.91 to 191.21. According to the industry distribution chart, Krsnaa Diagnostics ranks #47 out of 191 companies in the Medical Diagnostics & Research industry, placing it in the top 24.6%.
Is Krsnaa Diagnostics' Days Payable too high?
Krsnaa Diagnostics' current Days Payable of 98.29 is 31% below median its 10-year median of 141.76. Over the past 10 years, this metric has ranged from a low of 110.91 to a high of 191.21. The Medical Diagnostics & Research industry median Days Payable is 65.09. Krsnaa Diagnostics' value of 98.29 is 51% above this industry median. Based on the distribution chart, Krsnaa Diagnostics ranks #47 out of 191 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Krsnaa Diagnostics has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #47 out of 191 companies for Days Payable. This places Krsnaa Diagnostics in the top 25% of its industry — outperforming the majority of peers. The industry median Days Payable is 65.09. Krsnaa Diagnostics' value of 98.29 is 51% above this benchmark. Historically, Krsnaa Diagnostics' own Days Payable has ranged from 110.91 to 191.21 over the past decade. While the company's 10-year median is 141.76 vs. the industry median of 65.09, Krsnaa Diagnostics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.09, based on 191 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krsnaa Diagnostics's current Days Payable of 98.29 is 51% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Krsnaa Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krsnaa Diagnostics's current Days Payable is 98.29, which is 31% below median its own 10-year median of 141.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹904.34, compared to a current price of ₹556.90 — trading 38.4% below its estimated fair value. The current Days Payable is 98.29, which is 31% below median its 10-year median of 141.76 and 51% above the Medical Diagnostics & Research industry median of 65.09. Krsnaa Diagnostics' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Days Payable is 98.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?
Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued.
The current stock price of ₹556.90 is trading 38.4% below its estimated GF Value™ of ₹904.34.
GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.
Key valuation signals for NSE:KRSNAA:
Days Payable: 98.29 (31% below median its 10-year median of 141.76)
GF Value™: ₹904.34 vs. price of ₹556.90 (38.4% below fair value)
Industry Position: 51% above the Medical Diagnostics & Research median (#47 of 191)
No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
72GF Score
Get the complete analysis for NSE:KRSNAA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRSNAA has been successfully added to your 
